PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis: A systematic review and meta-analysis.

Abstract Intranasal corticosteroids (INS) (corticosteroid nasal sprays) and oral antihistamines (OA) are two of the most common treatments for patients with allergic rhinitis (AR). To our knowledge, there are no systematic reviews on this topic including trials published after 2007.
PMID
Related Publications

Capsaicin for non-allergic rhinitis.

Systemic and topical antibiotics for chronic rhinosinusitis.

Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.

Efficacy of intranasal antihistamine in the treatment of allergic rhinitis: a meta-analysis.

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials.

Authors

Mayor MeshTerms
Keywords
Journal Title american journal of rhinology & allergy
Publication Year Start




PMID- 28234147
OWN - NLM
STAT- MEDLINE
DA  - 20170224
DCOM- 20170310
LR  - 20170310
IS  - 1945-8932 (Electronic)
IS  - 1945-8932 (Linking)
VI  - 31
IP  - 1
DP  - 2017 Jan 09
TI  - Intranasal corticosteroids compared with oral antihistamines in allergic
      rhinitis: A systematic review and meta-analysis.
PG  - 19-28
LID - 10.2500/ajra.2016.30.4397 [doi]
AB  - BACKGROUND: Intranasal corticosteroids (INS) (corticosteroid nasal sprays) and
      oral antihistamines (OA) are two of the most common treatments for patients with 
      allergic rhinitis (AR). To our knowledge, there are no systematic reviews on this
      topic including trials published after 2007. OBJECTIVE: To compare INS with
      nonsedating OAs as treatments for AR. METHODS: The systematic review and
      meta-analysis were based on the Grades of Recommendation, Assessment,
      Development, and Evaluation principles and the Patient, Intervention, Comparison,
      and Outcome approach. Primary literature was searched up to January 22, 2015.
      Criteria for eligibility were randomized controlled trials that compared the
      efficacy and/or adverse effects of INS and OA in patients with AR. Continuous
      outcome data were analyzed by using standardized mean differences (SMD) for
      multiple outcome measures, and mean differences in the case of a single study or 
      outcome. Pooled estimates of effects, 95% confidence interval (CI), were
      calculated by using random-effects models. RESULTS: The meta-analysis included
      five randomized controlled trials with a total of 990 patients. INS were superior
      to OAs in improving total nasal symptoms score (SMD -0.70 [95% CI, -0.93 to
      -0.47]) and in relieving the following: nasal obstruction (SMD -0.56 [95% CI,
      -0.82 to -0.29]), rhinorrhea (SMD -0.47 [95% CI, -1.00 to 0.05]), nasal itching
      (SMD -0.42 [95% CI, -0.65 to -0.18]), sneezing (SMD -0.52 [95% CI, -0.73 to
      -0.32]), and quality of life mean difference -0.90 [95% CI, -1.18 to -0.62]).
      There was no difference in relief of ocular symptoms (SMD -0.08 [95% CI, -0.23 to
      0.08]). In addition, four randomized controlled trials were included in a
      narrative analysis. The results in the narrative analysis were comparable with
      those found in the meta-analysis. CONCLUSION: INS were superior to OAs in
      improving nasal symptoms and quality of life in patients with AR.
FAU - Juel-Berg, Nanna
AU  - Juel-Berg N
AD  - Department of Dermatology and Allergology, Copenhagen University Hospital,
      Gentofte, Denmark.
FAU - Darling, Peter
AU  - Darling P
FAU - Bolvig, Julie
AU  - Bolvig J
FAU - Foss-Skiftesvik, Majken H
AU  - Foss-Skiftesvik MH
FAU - Halken, Susanne
AU  - Halken S
FAU - Winther, Lone
AU  - Winther L
FAU - Hansen, Kirsten Skamstrup
AU  - Hansen KS
FAU - Askjaer, Nikolaj
AU  - Askjaer N
FAU - Heegaard, Steffen
AU  - Heegaard S
FAU - Madsen, Anders R
AU  - Madsen AR
FAU - Opstrup, Morten S
AU  - Opstrup MS
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
PL  - United States
TA  - Am J Rhinol Allergy
JT  - American journal of rhinology & allergy
JID - 101490775
RN  - 0 (Adrenal Cortex Hormones)
SB  - IM
MH  - Administration, Intranasal
MH  - Administration, Oral
MH  - Adrenal Cortex Hormones/*administration & dosage
MH  - Humans
MH  - Quality of Life
MH  - Rhinitis, Allergic/*drug therapy
MH  - Treatment Outcome
EDAT- 2017/02/25 06:00
MHDA- 2017/03/11 06:00
CRDT- 2017/02/25 06:00
AID - 10.2500/ajra.2016.30.4397 [doi]
PST - ppublish
SO  - Am J Rhinol Allergy. 2017 Jan 9;31(1):19-28. doi: 10.2500/ajra.2016.30.4397.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>